Jane Street Group, LLC Puma Biotechnology, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $444 Billion
  • Q4 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 17, 2021
BUY
$7.78 - $12.13 $139,262 - $217,127
17,900 Added 104.07%
35,100 $360,000
Q3 2020

Nov 17, 2020
BUY
$9.5 - $11.14 $94,050 - $110,286
9,900 Added 135.62%
17,200 $174,000
Q2 2018

Aug 15, 2018
BUY
$48.3 - $68.25 $159,390 - $225,225
3,300 Added 82.5%
7,300 $432,000
Q3 2017

Nov 14, 2017
BUY
$72.0 - $119.75 $288,000 - $479,000
4,000
4,000 $479,000

Others Institutions Holding PBYI

# of Institutions
110
Shares Held
28.3M
Call Options Held
27.9K
Put Options Held
3.4K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $155M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email